Skip to main content

Books in Immunology

Elsevier's Immunology collection equips researchers with valuable insights to address the complexities of the immune system and its role in health and disease, offering original research, insightful analysis, and current theory on diagnosing, managing, and advancing treatments for allergies, asthma, and immunologic disorders.

    • Mechanisms and Therapy of Liver Cancer

      • 1st Edition
      • Volume 149
      • February 10, 2021
      • English
      • Hardback
        9 7 8 0 1 2 8 2 4 0 3 0 4
      • eBook
        9 7 8 0 1 2 8 2 4 0 3 1 1
      Mechanisms and Therapy of Liver Cancer, Volume 149, presents the latest information on the incidence and mortality of liver cancer research and how it has gained significant momentum because of its direct causative association with obesity-induced fatty liver disease. The literature on liver cancer is moving fast with exciting, novel findings, providing new insights reflected in the following updated chapters: Introduction and molecular classification of HCC, Signaling Pathways in Liver Cancer, HCV and HCC, NASH and HCC, Microbiome and Metabolic Abnormalities in HCC, Systemic Therapy of Liver Cancer, Immunotherapy of Liver Cancer, and Desmoplastic Tumor Microenvironment and Intrahepatic Cholangiocarcinoma Progression: Mechanisms and Therapeutic Implications.
    • Advances in Immunology

      • 1st Edition
      • Volume 151
      • October 14, 2021
      • Frederick W. Alt
      • English
      • Hardback
        9 7 8 0 1 2 8 2 4 5 9 9 6
      • eBook
        9 7 8 0 3 2 3 8 5 0 8 5 8
      Advances in Immunology, Volume 151, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology.
    • Advances in Immunology

      • 1st Edition
      • Volume 150
      • June 25, 2021
      • Frederick W. Alt
      • English
      • Hardback
        9 7 8 0 1 2 8 2 4 5 9 8 9
      • eBook
        9 7 8 0 3 2 3 8 5 0 8 4 1
      Advances in Immunology, Volume 150, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology.
    • Systemic Lupus Erythematosus

      • 2nd Edition
      • April 7, 2020
      • George C. Tsokos
      • English
      • Paperback
        9 7 8 0 1 2 8 1 4 5 5 1 7
      • eBook
        9 7 8 0 1 2 8 1 4 5 5 2 4
      This completely updated and expanded 2nd edition of Systemic Lupus Erythematosus, A Manual includes topics not covered previously with contributors who are at the forefront of each specific topic and with a global appeal. Each chapter is short and is presented critically with selected references, which should be valuable to a wider audience. This book combines basic with clinical science to help internists and specialists in the diagnosis and management of patients with SLE. It is a quick referral for people in the pharmaceutical industry in their efforts to bring much-needed drugs. It provides all the needed information to basic researchers old and new alike, who wish to enter the field of lupus and systemic autoimmunity in general.
    • GPCR Signaling in Cancer

      • 1st Edition
      • Volume 145
      • February 20, 2020
      • English
      • Hardback
        9 7 8 0 1 2 8 2 0 2 3 0 2
      • eBook
        9 7 8 0 1 2 8 2 0 2 3 1 9
      GPCR Signaling in Cancer, Volume 145, the latest release in the Advances in Cancer Research series, highlights recent developments in the area of GPCRs and cancer biology. Chapters included in this volume cover several GPCRs and their downstream effectors as case examples to highlight their fundamental understanding and therapeutic potential. Specific chapters address the Role of GRKs and beta-arrestins in cancer, Atypical GPCRs in cancer, the Role of a chemokine receptor (CCR) 5 in cancer, Targeting G protein-coupled receptors for therapeutics in cancer, Emerging GPCR signaling pathways in cancer, and more. G protein-coupled receptors (GPCRs) constitute a large family of cell surface receptors which are involved in nearly every cellular and physiological event. These receptors can recognize a broad array of ligands and they are targeted by nearly one third of the currently prescribed drugs including anti-cancer therapeutics.
    • Stiehm's Immune Deficiencies

      • 2nd Edition
      • May 23, 2020
      • Kathleen E. Sullivan + 1 more
      • English
      • Hardback
        9 7 8 0 1 2 8 1 6 7 6 8 7
      • eBook
        9 7 8 0 1 2 8 1 7 2 9 5 7
      Stiehm’s Immune Deficiencies: Inborn Errors in Immunity, Second Edition, is ideal for physicians and other caregivers who specialize in immunology, allergies, infectious diseases and pulmonary medicine. It provides a validated source of information for care delivery to patients, covering approaches to diagnosis that use both new genetic information and emphasize screening strategies. Management has changed dramatically over the past five years, so approaches to infection and autoimmunity are emphasized in an effort to improve outcomes and disseminate new information on the uses of targeted therapy.
    • Advances in Cancer Research

      • 1st Edition
      • Volume 148
      • July 26, 2020
      • English
      • Hardback
        9 7 8 0 1 2 8 2 0 3 2 7 9
      • eBook
        9 7 8 0 1 2 8 2 0 3 2 8 6
      Advances in Cancer Research, Volume 148, the latest release in this ongoing, well-regarded serial, provides invaluable information on the exciting and fast-moving field of cancer research.
    • Infections in Systemic Autoimmune Diseases

      • 1st Edition
      • Volume 16
      • March 8, 2020
      • English
      • Paperback
        9 7 8 0 4 4 4 6 4 2 1 7 2
      • eBook
        9 7 8 0 4 4 4 6 4 2 1 8 9
      Infections in Systemic Autoimmune Diseases: Risk Factors and Management, Volume Sixteen describes the state-of-the-art of the risk factors and management treating the most common systemic autoimmune diseases (SADS). This updated volume consists of an introductory chapter that provides a brief overview of what different types of infectious diseases exist, followed by eight chapters detailing risk factors, guidelines and recommendations per different disease and bacterial infections. International in scope, the list of more than 20 contributors from Europa and America reads like a who’s who of clinical researchers in the field.
    • Receptor Tyrosine Kinases

      • 1st Edition
      • Volume 147
      • June 24, 2020
      • English
      • Hardback
        9 7 8 0 1 2 8 2 0 1 4 2 8
      • eBook
        9 7 8 0 1 2 8 2 0 1 8 3 1
      Receptor Tyrosine Kinases, Volume 147 in the Advances in Cancer Research series, provides invaluable information on the exciting and fast-moving field of cancer research in the area of Receptor Tyrosine Kinases (RTKs) in the context of major basic science and translational advances, their importance in the development of a large number of anti-cancer drugs over the decades, and a peek into postulated advances in the coming decades for a number of RTK. Chapters in this new release are contributed by a group of International leading scientists who have a rich history in this field.
    • Cancer Health Equity Research

      • 1st Edition
      • Volume 146
      • March 30, 2020
      • English
      • Hardback
        9 7 8 0 1 2 8 2 0 1 7 6 3
      • eBook
        9 7 8 0 1 2 8 2 0 1 7 7 0
      Cancer Health Equity Research, Volume 146 in the Advances in Cancer Research series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Pubertal Mammary Development as a ‘Susceptibility Window’ for Breast Cancer Disparity, Review of Patient Navigation Interventions to Address Barriers to Participation in Cancer Clinical Trials, Racial Disparities in Ovarian Cancer Research, Mighty Men: A Faith-Based Weight Loss Intervention to Reduce Cancer Risk in African American Men, Design of a Patient Navigation Intervention to Increase Rates of Surgery among African Americans with Early-Stage Lung Cancer, and much.